K8콢

ԴݾƵ괲ߣ 

ҹ꽲вٯҡ»վ꽲վɶطǿꁶһûϸ ȥһѵ˳㵴滹е㡰ζ

ɶȡζе˼

ͼƬ

ҿվɶ󾰵ҪǻᡰTTһȤЩϽ֡Ұζ ſҡȱͷβСζһžǡԼˡ 꽲؁Ȥ

һмСֹζӣͷʱʽ ڹҽطԭǸͷŇӣ

͵͵꽲мС̯糿ȥŻڼҰϸݹζֵùֺŇӣȥȻʱܾ̯

ġ桱Ҫʱ䣡

ϲՇվҲм Ʃ糿ʱߴůůɫҰζ

һǻƻʱϵְ̫Ұ ֻijʱ⡱ζ

ͼƬ ͵͵꽲иͷַС˻ Ҫеסײǽϻǰ̱껭ӣ

ܻʇӣǾֵֵȥ

ҿʱԣぶһ䡰ζȥǺõ Ҫʱ뿴ɶÁ

ؽ꽲ǁ

ͼƬ

ǩ»վ桢Ͻζͷվܺ

ַ¥Ʒ̳ۡ

źгչͼӡڡҪΪѡƷΪҪӡṩܡҪԴ󸺺ɡϵӡҪܼߵĴӡƷʺͱܼԻ᳡ĸʵʱļӦϵͳ칫ʵʱЭͬÿһϸڶ뾫һӡ֤˱ͼƷʸЧſɿ׿ԽƷʵˡҪñͼҪñͼ

̫ԭڽ

131չ˾2025ҵԤԤʵ־68.00Ԫ78.00Ԫͬȱ任Ϊ51.00%~73.00%

ɽ·ƽֵĿܼ

޸֮һ ΢ʱܹͨϸֳָܻ ȻܺõġԵлЧϰ֬ԸףMetabolic dysfunction-associated steatohepatitis, MASHԲѬȾþƾʱ޸ƾͻʧ ̫Ծ޸̻ᵼϸʣExtracellular matrixĴڳԭĸ֯𽥱ӲγɸάLiver fibrosis һ̲ӸԤתӲΰ

վͼ